Tag: Genentech

23andMe and Genentech Expand Cancer Study

Last year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about what role genes might play in how a person responds to bevacizumab, also known as Avastin®. (Avastin® is not approved by the FDA for treatment of metastatic breast cancer.) We were happy with the ...

Read more

Advocates for Women with Breast Cancer

In any big fight it helps to have someone in your corner and when it comes to breast cancer you want someone like Elyse Spatz Caplan and the people at Living Beyond Breast Cancer. Elyse, who herself was diagnosed and treated for breast cancer in 1991, oversees educational programming for Living Beyond ...

Read more

Participating in Metastatic Breast Cancer Research

Earlier this year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about how genes might play a role in how a person responds to bevacizumab, also known as Avastin®. (Avastin® is not approved by the FDA for treatment of metastatic breast cancer.) Since women began to ...

Read more

Breast Size Matters — But Not In The Way You Think

With Nick Eriksson Social norms and preferences aside, it turns out that breast size matters -- but not quite in the way you think. 23andMe’s latest research paper, published in the journal BMC Medical Genetics, shows that genetic factors influence whether women have double As or double Ds. This might ...

Read more

National Cancer Research Awareness Month

Cancer is not one disease, but many. Even looking specifically at breast cancer or sarcoma, the more researchers study these diseases, the more they understand that there are many different kinds of breast cancer and sarcoma. This has been one of the most challenging aspects of researching cures for ...

Read more

Breast Cancer Research Goes Online

Clinical trials are often conducted at major hospitals and medical centers.  As you can imagine, it can be expensive to use hospital resources and take a large amount of doctors’ and nurses’ time. It can also be difficult to find people to participate in clinical trials.  For those who do participate, it ...

Read more

Return to top